NIKARA KILPATRICK: Open Payments
NPI 1134675465 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 17 payments from 8 companies in 2025. Trend: 2023 $372 · 2024 $1,311 · 2025 $1,834
Food & beverage: $1,834
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $477 |
| Gilead Sciences, Inc. | 3 | $277 |
| Ardelyx, Inc. | 2 | $250 |
| Janssen Biotech, Inc. | 2 | $242 |
| Phathom Pharmaceuticals, Inc. | 2 | $238 |
| EVOKE PHARMA, INC. | 1 | $125 |
| Novo Nordisk Inc | 1 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $113 |
Products named: SKYRIZI, IBSRELA, TREMFYA, VOQUEZNA, GIMOTI, Epclusa, MAVYRET, Wegovy.
Industry payments across MS — which companies pay providers there.
